MAlignant GIant Cell tumor of tendon sheet - Tumore giganto-cellulare delle guaine tendinee maligno (MAGIC).

Title

Code

MAGIC

Type

Sperimentale

Start Year

2023

Status

In Corso

Principal Investigator

051-6366102

toni.ibrahim@ior.it

Ibrahim Toni, BSc, MSc, MD, PhD

Director

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies

Operational unit that carry out the study

complex unit

Osteoncologia, Sarcomi dell'osso e dei tessuti molli, e Terapie Innovative

Director

Ibrahim Toni, BSc, MSc, MD, PhD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. MAGIC.

Thursday 28 August 2025, 14:32

PG0004179_2023_Nulla osta DG_MAGIC - Palmerini.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

MAlignant GIant Cell tumor of tendon sheet - Tumore giganto-cellulare delle guaine tendinee maligno (MAGIC).

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in